What are Clinical Studies?

Clinical studies are carefully supervised and monitored research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. These studies may also show which medical approaches work best for certain illnesses or groups of people.

The purpose of clinical studies is research, so studies are designed to follow strict scientific standards with the goals of protecting patients and helping to produce reliable study results. Results from clinical studies may be important and have the potential to advance medical knowledge and help improve patient care. However, study results are not guaranteed and may not improve patient care for study participants, so it is important that you read and understand the patient consent materials that are provided to you prior to enrolling.

Participation in a clinical research study is voluntary and a personal decision that should be made after talking with your doctor and family.

Additional Information regarding the trial can be found at:

RECOVER is a clinical study for people who are about to start their first treatment for breast cancer. The purpose of this study is to compare eflapegrastim and pegfilgrastim (also known as Neulasta®*) while you receive TC chemotherapy for early-stage breast cancer, by collecting blood samples and will be looking at the number of white blood cells, including neutrophils, being produced by the body.

*Disclaimer Third Parties

All product and company names are trademarks (TM) or registered trademarks (®) of their respective holders. Use of them does not imply any affiliation, approval, license or endorsement by them.

Neulasta® is a registered trademark of Amgen Inc.

Terms of Use

Privacy Policy

Web Site Linking Policy

Eflapegrastim (also known as SPI-2012) is a medication currently being tested and has yet to receive approval from the Food and Drug Administration (FDA).

© 2017 Spectrum Pharmaceuticals, Inc. All Rights Reserved.

ROL170701700